Hetero Drugs Limited - Company Profile

Q: Who are the current directors of Hetero Drugs Limited?

The current directors of Hetero Drugs Limited are Bandi Vamsikrishna, Adisesha Giri Jagarapu, Parthasaradhi Reddy Bandi, Attunuri Venkatanarasa Reddy, Kalavathi Bandi, Gopal Reddy Annareddy, Sambi Reddy Jonnala, Kaza Sai Venkata Sharath Krishna.

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1993.

1993 Hyderabad, Telangana, India Active

Last Updated: February 07, 2026

Access Report

About Hetero Drugs Limited

Hetero Drugs Limited, a active public limited company, was established on 06 April 1993 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230TG1993PLC015582. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹3.45 Cr.

Formerly known as Hetero Drugs Private Limited. It upholds a compliant status. Employing 1,711 professional, Its leadership includes Bandi Vamsikrishna (Director), Adisesha Giri Jagarapu (Director), Parthasaradhi Reddy Bandi (Director). Past directors included Gopala Krishna Rampalli, Bandi Vamsikrishna, Adisesha Giri Jagarapu. It holds ₹954.50 Cr open charges and ₹3,713.38 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at #7-2-A2, Industrial Estate, Sanathnagar,, Hyderabad, Telangana, 500018.

Company Details

CIN/LLPIN
U24230TG1993PLC015582
Registration Number
015582
Incorporation Date
06 April 1993
Authorized Capital
₹10.00 Cr
Paid-Up Capital
₹3.45 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 10.00 Cr as on 07-02-2026
Paid Up Capital ₹ 3.45 Cr as on 07-02-2026
Company Age 32 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 954.50 Cr as on 07-02-2026
Satisfied Charges ₹ 3,713.38 Cr as on 07-02-2026
Revenue Growth **** 19.76% (FY 2023)
Profit Growth **** 65.07% (FY 2023)
Ebitda **** 13.14% (FY 2023)
Net Worth 8.05% (FY 2023)
Total Assets **** 8.62% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Hetero Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Hetero Drugs Limited?

Current Directors

Name	Designation	Appointment Date	Status
Bandi Vamsikrishna	Director	10 Apr 2008	Current
Adisesha Giri Jagarapu	Director	23 Sep 2021	Current
Parthasaradhi Reddy Bandi	Director	01 Apr 2008	Current
Attunuri Venkatanarasa Reddy	Director	28 Jan 1999	Current
Kalavathi Bandi	Director	01 Apr 2015	Current
Gopal Reddy Annareddy	Director	21 Dec 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	28 Sep 2017	Past
Pramod Abcsdd	Additional Director	25 Sep 2008	Past
Pramod Abcsdd	Additional Director	25 Nov 2021	Past
Pramod Abcsdd	Company Secretary	17 Feb 2024	Past
Pramod Abcsdd	Additional Director	28 Sep 2017	Past
Pramod Abcsdd	Company Secretary	02 Jul 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hetero Drugs.

Hetero Drugs Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.76% increase. The company also saw a substantial improvement in profitability, with a 65.07% increase in profit. The company's net worth moved up by a moderate rise of 8.05%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

19.76%

*******

Revenue from Operations

*******

19.54%

*******

Total Assets

*******

8.62%

*******

Profit or Loss

*******

65.07%

*******

Net Worth

*******

8.05%

*******

EBITDA

*******

13.14%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hetero Drugs?

In 2023, Hetero Drugs had a promoter holding of 76.24% and a public holding of 23.76%. The company had 5 Subsidiaries and 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹9,544,983,602.00

Satisfied Charges

₹37,133,800,000.00

Charges Breakdown by Lending Institutions

Idbi Trusteeship Services Limited : 850.00 Cr
Industrial Development Bank Of India : 81.00 Cr
Idbi Bank : 15.61 Cr
Others : 6.14 Cr
Bank Of India : 1.76 Cr

Latest Charge Details

Date	Lender	Amount	Status
04 Sep 2025	Bank Of India	₹1.05 M	Open
04 Sep 2025	Bank Of India	₹1.40 M	Open
01 Sep 2025	Bank Of India	₹0.80 M	Open
22 Aug 2025	Bank Of India	₹1.49 M	Open
29 Jul 2025	Bank Of India	₹0.90 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Hetero Drugs?

Hetero Drugs has a workforce of 1711 employees as of Jul 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hetero Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetero Drugs's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hetero Drugs

Recent Activity within the Organization

Director Appointment

Progress on Kaza Sai Venkata Sharath Krishna was appointed as a Company Secretary was appointed as a Company Secretary on 13 Jan 2026 & has been associated with this company since 2 months 1 day . was documented.
13 Jan 2026
Annual General Meeting

Hetero Drugs Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
29 Sep 2025
Charges

A charge with Bank Of India amounted to Rs. 0.11 Cr with Charge ID 101163367 was registered on 04 Sep 2025. was recorded as a recent event.
04 Sep 2025
Charges

The activity A charge with Bank Of India amounted to Rs. 0.14 Cr with Charge ID 101163398 was registered on 04 Sep 2025. was completed.
04 Sep 2025
Charges

A charge with Bank Of India amounted to Rs. 0.08 Cr with Charge ID 101156685 was registered on 01 Sep 2025. was recorded as a recent event.
01 Sep 2025
Charges

A charge with Bank Of India amounted to Rs. 0.15 Cr with Charge ID 101156680 was registered on 22 Aug 2025. was recorded as a recent event.
22 Aug 2025

Explore recent activity and updates - View Recent Activity